TABLE 1 Pharmacokinetics of exendin-4 in portal and peripheral blood after administration via the intestine, or by intravelous injection
Recent data from the ATTAIN-MAINTAIN trial showed that patients transitioning to orforglipron after injectable GLP-1 therapy maintained their weight loss with minimal regain (approximately 0.9 kg after semaglutide transition), suggesting that oral maintenance strategies could minimize the lean mass depletion seen with prolonged high-dose injectable therapy
For supplement users especially, diet plays a critical role because the gut microbiome is directly influenced by what you eat
During adipocyte remodeling, lipid droplet configurations regulate insulin sensitivity through F-actin and G-actin reorganization
NADH Dr Lapp recommends 10-20mg of NADH daily, which may take three to six months to work, with only a "subtle" response
Your PlexusDx clinical team can adjust your prescription based on your side effect profile